Alloy vs Royal Medical Center
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Royal Medical Center
Best for Buyers who prioritize a named, credentialed MD founder (Dr. Dagoberto Rodriguez, Emory-trained, 30+ years of practice) and an itemized dose-strength pricing ladder over the lowest-possible monthly cost. Fit for buyers who already need HRT/TRT or a broad peptide adjunct stack and want to consolidate GLP-1 + hormone + peptide programs under one clinic. NOT for buyers who want semaglutide, oral/ODT/troche formats, the lowest cash-pay price (Trimi $99, Coby $99/$179, AVARA $229/$279, Trava are all cheaper), explicit state availability, a named pharmacy partner, a LegitScript badge, or a written refund policy.Starting at $450/mo
Side-by-Side Comparison
| Feature | Alloy | Royal Medical Center |
|---|---|---|
| Overall Score | ✓7.4/10 | 5.1/10 |
| Starting Price | ✓$80/mo | $450/mo |
| Editorial Rating | ✓3.7 ★ /5 | 2.6 ★ /5 |
| Features | 8 features | ✓10 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Royal Medical Center
Pros
- ✓Strong, verifiable physician founder: Dr. Dagoberto Rodriguez M.D. — Emory University residency, former chairman of Coral Springs Medical Center (1997-2000), Blue Cross Blue Shield peer review committee member, University of Miami School of Medicine teaching faculty since 2004. Unusually strong credentialing vs typical DTC compounded-GLP-1 storefronts.
- ✓Tirzepatide pricing is fully itemized by dose-strength tier ($450 / $650 / $800 / $1,100) — significantly more transparent than the 'starting at $X' floor common to DTC peers (Trimi, Coby, AVARA Rx all advertise floors only).
- ✓All-inclusive pricing claim: medication + supplies + injections + lab monitoring + physician consultations + follow-ups bundled at the monthly tier rate (verbatim from /weight-loss/ page).
- ✓Broad adjunct catalog (HRT, TRT, peptides, ED, hair, vitamins) suggests an established multi-program clinic vs single-product GLP-1 startup.
- ✓Florida physician footprint + 30+ years of practice history is a positive E-E-A-T signal for buyers prioritizing physician-led care.
Cons
- ✗Operating legal entity / LLC suffix NOT disclosed verbatim on the homepage, about page, or contact page — only 'Royal Medical Center' brand surfaced.
- ✗Pharmacy partner NOT named — only generic 'US-based Pharmacy' language on the tirzepatide product page and 'discreetly shipped from the pharmacy' on the homepage. Buyers cannot independently verify the dispensing pharmacy's licensure or 503A/503B status.
- ✗LegitScript verification badge NOT displayed on the homepage, weight-loss page, or product pages (none of the audited pages surfaced a LegitScript seal).
- ✗State availability NOT enumerated — site says 'nationwide' but provides no 50-state list or state-restriction notice. The presence of a California-only SKU (hair regrowth) suggests at least some state-specific compliance handling that is not surfaced for the GLP-1 program.
- ✗Cloudflare challenge wall (HTTP 403 to non-browser User-Agents) prevented direct live verification; this audit relied on a Wayback Machine snapshot from Oct 16 2025, so the data may not reflect the current site state.
- ✗Headline 'starting at $116/mo' for weight loss is inconsistent with the actual tirzepatide product page floor of $450/mo — the $116 figure likely refers to a different program (possibly testosterone or hormone therapy) and may mislead GLP-1 shoppers.
- ✗Semaglutide NOT offered for weight loss — tirzepatide-only. Buyers wanting a sema option (cheaper at most DTC peers) must look elsewhere.
- ✗No semaglutide, no Wegovy, no Zepbound, no Foundayo, no oral/ODT/troche formats — injection-only, single-molecule.
- ✗Refund / cancellation policy NOT surfaced on the homepage, weight-loss page, or product page.
- ✗Insurance acceptance NOT addressed — cash-pay model implied but not stated.
- ✗Lab work requirement: lab monitoring is bundled into the all-inclusive program, but it is unclear whether baseline labs are required before the first shipment or can be drawn after starting therapy.
- ✗BBB profile NOT found (BBB search for 'royal medical centers' returned zero results as of 2026-05-28).
- ✗Pricing is mid-to-high tier ($450 floor for tirz) vs the lowest-cost DTC compounded-tirz market ($179-$279 floor at Coby, Trava, AVARA Rx, Trimi).
Our Verdict
Alloy edges out Royal Medical Center with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. Royal Medical Center remains a solid alternative, especially if you're looking for Buyers who prioritize a named, credentialed MD founder (Dr. Dagoberto Rodriguez, Emory-trained, 30+ years of practice) and an itemized dose-strength pricing ladder over the lowest-possible monthly cost. Fit for buyers who already need HRT/TRT or a broad peptide adjunct stack and want to consolidate GLP-1 + hormone + peptide programs under one clinic. NOT for buyers who want semaglutide, oral/ODT/troche formats, the lowest cash-pay price (Trimi $99, Coby $99/$179, AVARA $229/$279, Trava are all cheaper), explicit state availability, a named pharmacy partner, a LegitScript badge, or a written refund policy..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Alloy and Royal Medical Center head-to-heads in the same category.
- Alloy vs CoreAge Rx
- Alloy vs TrimRx
- Alloy vs Amazon One Medical
- Royal Medical Center vs NovoCare Pharmacy
- Royal Medical Center vs Vytora Health
- Royal Medical Center vs Enhance MD
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.